Fig. 1From: Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administrationComparison of median teicoplanin trough concentrations in intravenously- and subcutaneously-treated patients during the first 2 weeks of treatment. Data are presented as median and interquartile ranges of teicoplanin trough levels available each day after treatment initiationBack to article page